(2-(4-Amino-6-((4-fluorobenzyl)amino)-1,3,5-triazin-2-yl)-3-fluorophenyl)methanol

ID: ALA4521172

PubChem CID: 155542383

Max Phase: Preclinical

Molecular Formula: C17H15F2N5O

Molecular Weight: 343.34

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(NCc2ccc(F)cc2)nc(-c2c(F)cccc2CO)n1

Standard InChI:  InChI=1S/C17H15F2N5O/c18-12-6-4-10(5-7-12)8-21-17-23-15(22-16(20)24-17)14-11(9-25)2-1-3-13(14)19/h1-7,25H,8-9H2,(H3,20,21,22,23,24)

Standard InChI Key:  CZASNSHBLXHCIH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   30.5772  -11.8410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5761  -12.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2841  -13.0695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9938  -12.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9910  -11.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2823  -11.4321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6941  -11.4274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4036  -11.8350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.1093  -11.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1067  -10.6064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3924  -10.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6897  -10.6136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8183  -11.8307    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.5247  -11.4198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3865   -9.3835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2799  -10.6149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5710  -10.2085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.2338  -11.8261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2329  -12.6428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9411  -13.0490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6484  -12.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6431  -11.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9343  -11.4141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3580  -13.0433    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.7089  -13.0714    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  5  7  1  0
  9 13  1  0
 13 14  1  0
 11 15  1  0
  6 16  1  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
  4 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4521172

    ---

Associated Targets(Human)

GPR68 Tchem Ovarian cancer G-protein coupled receptor 1 (279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.34Molecular Weight (Monoisotopic): 343.1245AlogP: 2.50#Rotatable Bonds: 5
Polar Surface Area: 96.95Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.53CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: -1.19

References

1. Yu X, Huang XP, Kenakin TP, Slocum ST, Chen X, Martini ML, Liu J, Jin J..  (2019)  Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).,  62  (16): [PMID:31298539] [10.1021/acs.jmedchem.9b00869]

Source